06:08 , May 20, 2019 |  BioCentury  |  Finance

Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri

Seven years after its first foray into hearing loss, Boehringer Ingelheim Venture Fund is investing in U.K. stem cell therapy company Rinri. On May 20, Boehringer's corporate venture fund co-led a £1.4 million ($1.8 million)...
07:00 , Aug 1, 2016 |  BC Week In Review  |  Financial News

Fast BioPharma completes venture financing

Fast BioPharma Ltd. , Oxford, U.K.   Business: Cancer   Date completed: 2016-07-27   Type: Venture financing   Raised: Not disclosed   Investor: BioCity   Note: The amount raised is not disclosed.  ...
07:00 , May 21, 2015 |  BC Innovations  |  Translation in Brief

Nurturing Scottish innovation

If serendipity can be manufactured, BioCity Scotland may have the inside track with its newly launched innovation hub. The incubator space opened in 2012 at the site of a former Merck Sharp & Dohme Corp....
08:00 , Feb 25, 2013 |  BC Week In Review  |  Company News

Edelris, Sygnature Discovery, Syncom B.V., Taros Chemicals GmbH & Co. KG, AstraZeneca, Bayer, Lundbeck, J&J, Mercachem B.V., Merck KGaA, Sanofi, Innovative Medi

The EU's IMI announced the launch of the European Lead Factory, an EU-wide public-private discovery partnership to accelerate early stage drug development. The five-year project comprises 30 partners and includes the creation of a small...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

Merck, BioCity Nottingham Ltd., Roslin Foundation pharmaceuticals news

Merck gifted its former R&D facility in Newhouse, Scotland, to the BioCity Scotland research cluster for biotech, pharma, med-tech and healthcare companies. The 23 acre site includes 130,000 square feet of laboratory and office space,...
01:20 , Jan 13, 2012 |  BC Extra  |  Company News

Former Merck facility finds new life as Scottish research hub

Merck & Co. Inc. (NYSE:MRK) gifted its former R&D facility in Newhouse, Scotland, to the BioCity Scotland research cluster for biotech, pharma, med-tech and healthcare companies. The 23 acre site includes 130,000 square feet of...
07:00 , Oct 12, 2009 |  BioCentury  |  Finance

Ebb & Flow

Facet Biotech Corp. (NASDAQ:FACT) executives seem confident that investors aren't going to take the bait on the $14.50 per share tender offer from Biogen Idec Inc. (NASDAQ:BIIB) - and they cite the company's stock price...